Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.

Mediators Inflamm · 2013 · PMC3819752 · PMID 24249974

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

A recent phase 2 trial found a nonsignificant trend toward better survival in patients with severe sepsis treated with eritoran tetrasodium, a TLR-4 antagonist [ 15 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.